L007 Pill - purple oval, 19mm

Pill with imprint L007 is Purple, Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Divalproex sodium is used in the treatment of Bipolar Disorder; Mania; Migraine Prevention; Seizures; Epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L007

Divalproex Sodium Delayed-Release

Imprint: L007
Strength: 500 mg
Color: Purple
Size: 19.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Lupin Pharmaceuticals, Inc
Inactive Ingredients: D&C Red No. 30, FD&C Blue No. 2, ferric oxide yellow, hypromelloses, silicon dioxide, triethyl citrate, microcrystalline cellulose, hypromellose phthalate, low substituted hydroxypropyl cellulose, shellac, magnesium silicate, hydroxypropyl cellulose, magnesium stearate, propylene glycol, titanium dioxide, ferrosoferric oxide, corn starch
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
68084-0315 (Discontinued)	Amerisource Health Services
68180-0267 (Discontinued)	Lupin Pharmaceuticals, Inc.
54868-6072	Physicians Total Care Inc. (repackager)